Skip to main content
All lobbying filings

HANCE SCARBOROUGH

HANCE SCARBOROUGH filed a Q1 report for ALLIANCE FOR PHARMACY COMPOUNDING on April 18, 2026, reporting $50,000 in lobbying income.

Lobbying for ALLIANCE FOR PHARMACY COMPOUNDING · Non-profit association promoting the practice of pharmacy compounding

All filings by HANCE SCARBOROUGH · Everything ALLIANCE FOR PHARMACY COMPOUNDING has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 18, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Texas

Official filing document

 Lobbyists on this filing 2
  • MICHAEL TOMBERLIN
    Previously held: Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep., Louie Gohmert
  • THERESA REED
    Previously held: Leg. Director for Multiple Members

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3
Health Issues

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2026 Appropriations. Drug Shortages SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations

Pharmacy

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2026 Appropriations. Drug Shortages SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations

Budget/Appropriations

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2026 Appropriations. SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations

 Bills named in this filing 3
  • H.R. 6509
    SAFE Drugs Act of 2025
  • S. 3794
    SAFE Drugs Act of 2026
  • H.R. 5316
    Drug Shortage Compounding Patient Access Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem